The arachidonic acid effect on platelet nitric oxide level

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 11, 2009, Pages 1084-1092

  Signorello, Maria Grazia ^a   Segantin, Alessia ^a   Leoncini, Giuliana ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Arachidonic acid; Human platelet; NADPH oxidase; Nitric oxide; Nitric oxide synthase; Protein kinase C; Superoxide anion

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARACHIDONIC ACID; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ARACHIDONIC ACID; BLOOD PLATELETS; CALCIUM; CELL MEMBRANE; CYCLIC GMP; ENZYME ACTIVATION; HUMANS; NADPH OXIDASE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PHOSPHORYLATION; PHOSPHOTHREONINE; PLATELET AGGREGATION; PROTEIN KINASE C; PROTEIN TRANSPORT; SUPEROXIDES;

EID: 70349289078     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.07.003     Document Type: Article

References (50)

1. Chakraborti S. Phospholipase A(2) isoforms: a perspective. Cell. Signal. 15 (2003) 637-665
2. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9 (1995) 484-496
3. Balsinde J., and Balboa M.A. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell. Signal. 17 (2005) 1052-1062
4. Börsch-Haubold A.G., Kramer R.M., and Watson S.P. Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J. Biol. Chem. 270 (1995) 25885-25892
5. 2+ mobilizing action of arachidonic acid in human platelets. Biochim. Biophys. Acta 1012 (1989) 97-102
6. Fischer T.H., Griffin A.M., Barton D.W., and White G.C. Kinetic evidence that arachidonate-induced calcium efflux from platelet microsomes involves a carrier-type ionophoric mechanism. Biochim. Biophys. Acta 1022 (1990) 215-228
7. Alonso M.T., Sanchez A., and Garcia-Sancho J. Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin. Biochem. J. 272 (1990) 435-443
8. Rao G.N., Baas A.S., Glasgow W.C., Eling T.E., Runge M.S., and Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269 (1994) 32586-32591
9. Hii C.S., Ferrante A., Edwards Y.S., Huang Z.H., Hartfield P.J., Rathjen D.A., Poulos A., and Murray A.W. Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J. Biol. Chem. 270 (1995) 4201-4204
10. Paine E., Palmantier R., Akiyama S.K., Olden K., and Roberts J.D. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J. Biol. Chem. 275 (2000) 11284-11290
11. Rizzo M.T., and Carlo-Stella C. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells. Blood 88 (1996) 3792-3800
12. Cui X.L., and Douglas J.G. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3771-3776
13. Madamanchi N.R., Bukoski R.D., Runge M.S., and Rao G.N. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells. Oncogene 16 (1998) 417-422
14. Muthalif M.M., Benter I.F., Karzoun N., Fatima S., Harper J., Uddin M.R., and Malik K.U. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12701-12706
15. Mayer B., and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22 (1997) 477-481
16. Radomski M.W., Palmer R.M., and Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92 (1987) 181-187
17. Radomski M.W., Palmer R.M., and Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5193-5197
18. Oess S., Icking A., Fulton D., Govers R., and Müller-Esterl W. Subcellular targeting and trafficking of nitric oxide synthases. Biochem. J. 396 (2006) 401-409
19. Michell B.J., Chen Z.P., Tiganis T., Stapleton D., Katsis F., Power D.A., Sim A.T., and Kemp B.E. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J. Biol. Chem. 276 (2001) 17625-17628
20. 2+. FEBS Lett. 192 (1985) 189-193
21. López-Nicolás R., López-Andreo M.J., Marín-Vicente C., Gómez-Fernández J.C., and Corbalán-García S. Molecular mechanisms of PKCalpha localization and activation by arachidonic acid. The C2 domain also plays a role. J. Mol. Biol. 357 (2006) 1105-1120
22. O'Flaherty J.T., Chadwell B.A., Kearns M.W., Sergeant S., Daniel L.W., and Protein kinases C. translocation responses to low concentrations of arachidonic acid. J. Biol. Chem. 276 (2001) 24743-24750
23. Nishizaki T., Nomura T., Matsuoka T., Enikolopov G., and Sumikawa K. Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Brain Res. Mol. Brain Res. 69 (1999) 263-272
24. Shinomura T., Asaoka Y., Oka M., Yoshida K., and Nishizuka Y. Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5149-5153
25. Hirata K., Kuroda R., Sakoda T., Katayama M., Inoue N., Suematsu M., Kawashima S., and Yokoyama M. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25 (1995) 180-185
26. Matsubara M., Hayashi N., Jing T., and Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J. Biochem. 133 (2003) 773-781
27. Chiang T.M., Woo-Rasberry V., and Cole F. Role of platelet endothelial form of nitric oxide synthase in collagen-platelet interaction: regulation by phosphorylation. Biochim. Biophys. Acta 1592 (2002) 169-174
28. Huang Z.H., Hii C.S., Rathjen D.A., Poulos A., Murray A.W., and Ferrante A. N-6 and n-3 polyunsaturated fatty acids stimulate translocation of protein kinase Calpha, -betaI, -betaII and -epsilon and enhance agonist-induced NADPH oxidase in macrophages. Biochem. J. 325 (1997) 553-557
29. Dana R., Malech H.L., and Levy R. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem. J. 297 (1994) 217-223
30. Shiose A., and Sumimoto H. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J. Biol. Chem. 275 (2000) 13793-13801
31. Park J.W., and Babior B.M. Activation of the leukocyte NADPH oxidase subunit p47phox by protein kinase C. A phosphorylation-dependent change in the conformation of the C-terminal end of p47phox. Biochemistry 36 (1997) 7474-7480
32. Pignatelli P., Lenti L., Sanguigni V., Frati G., Simeoni I., Gazzaniga P.P., Pulcinelli F.M., and Violi F. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H41-48
33. Leoncini G., Bruzzese D., and Signorello M.G. A role for PLCgamma2 in platelet activation by homocysteine. J. Cell. Biochem. 100 (2007) 1255-1265
34. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962) 927-929
35. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
36. Raiteri L., Stigliani S., Siri A., Passalacqua M., Melloni E., Raiteri M., and Bonanno G. Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels. Biochem. Pharmacol. 69 (2005) 159-168
37. Nardi M., Feinmark S.J., Hu L., Li Z., and Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J. Clin. Invest. 113 (2004) 973-980
38. Freedman J.E., and Keaney J.F. Nitric oxide and superoxide detection in human platelets. Methods Enzymol. 301 (1999) 61-70
39. Armstrong P.C., Truss N.J., Ali F.Y., Dhanji A.A., Vojnovic I., Zain Z.N., Bishop-Bailey D., Paul-Clark M.J., Tucker A.T., Mitchell J.A., and Warner T.D. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2. J. Thromb. Haemost. 6 (2008) 1933-1943
40. Jiang X., Yang F., Tan H., Liao D., Bryan R.M., Randhawa J.K., Rumbaut R.E., Durante W., Schafer A.I., Yang X., and Wang H. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2515-2521
41. Signorello M.G., Segantin A., Passalacqua M., and Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitric oxide 20 (2009) 104-113
42. Leo R., Praticò D., Iuliano L., Pulcinelli F.M., Ghiselli A., Pignatelli P., Colavita A.R., FitzGerald G.A., and Violi F. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation 95 (1997) 885-891
43. Seno T., Inoue N., Gao D., Okuda M., Sumi Y., Matsui K., Yamada S., Hirata K.I., Kawashima S., Tawa R., Imajoh-Ohmi S., Sakurai H., and Yokoyama M. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb. Res. 103 (2001) 399-409
44. Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., Becker B.F., Theisen K., Klauss V., and Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100 (2002) 917-924
45. Pignatelli P., Sanguigni V., Lenti L., Ferro D., Finocchi A., Rossi P., and Violi F. gp91phox-dependent expression of platelet CD40 ligand. Circulation 110 (2004) 1326-1329
46. el Benna J., Ruedi J.M., and Babior B.M. Cytosolic guanine nucleotide-binding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase. Transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to the submembranous actin cytoskeleton during oxidase activation. J. Biol. Chem. 269 (1994) 6729-6734
47. Inanami O., Johnson J.L., McAdara J.K., Benna J.E., Faust L.R., Newburger P.E., and Babior B.M. Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J. Biol. Chem. 273 (1998) 9539-9543
48. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., and Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111 (2003) 1201-1209
49. Dixon L.J., Hughes S.M., Rooney K., Madden A., Devine A., Leahey W., Henry W., Johnston G.D., and McVeigh G.E. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Hypertension 18 (2005) 839-843
50. Moss M.B., Brunini T.M., Soares De Moura R., Novaes Malagris L.E., Roberts N.B., Ellory J.C., Mann G.E., and Mendes Ribeiro A.C. Diminished l-arginine bioavailability in hypertension. Clin. Sci. 107 (2004) 391-397